Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
19,362
+10,197
+111% +$679K 0.09% 181
2026
Q1
$576K Sell
9,165
-210
-2% -$14.6K 0.05% 335
2025
Q4
$622K Buy
9,375
+1,449
+18% +$93.7K 0.06% 265
2025
Q3
$533K Buy
7,926
+194
+3% +$15.4K 0.05% 293
2025
Q2
$675K Buy
+7,732
New +$606K 0.07% 230
2022
Q1
Sell
-2,064
Closed -$277K 118
2021
Q4
$277K Buy
+2,064
New +$297K 0.08% 74

Other funds holding DXCM

Inspire Advisors's DXCM Position: Q2 2026 in Review

Inspire Advisors increased its DexCom (DXCM) stake by 111% in Q2 2026, buying an estimated $679K and bringing the position to 19,362 shares worth $1.3M. The position accounts for 0.09% of the portfolio, ranked #181.

Inspire Advisors first reported a position in DXCM in Q4 2021 and has held it in 6 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Inspire Advisors held 19,362 shares of DexCom worth $1.3M as of Q2 2026.
  • Inspire Advisors bought 10,197 DexCom shares in Q2 2026, an estimated $679K.
  • DexCom made up 0.09% of Inspire Advisors's portfolio in Q2 2026, its #181 holding.
  • Inspire Advisors first reported a position in DexCom in Q4 2021 and has held it in 6 quarters since.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.